APC anti-mouse/human CD45R/B220 Antibody APC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_APC_090507
C57BL/6 mouse splenocytes stained with RA3-6B2 APC
  • RA3-6B2_APC_090507
    C57BL/6 mouse splenocytes stained with RA3-6B2 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103211 25 µg NOK231
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103212 100 µg NOK726
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45R antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  4. Atalis A, et al. 2022. J Control Release. 347:476. PubMed
  5. Erickson JJ, et al. 2022. Nature. 606:769. PubMed
  6. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  7. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  8. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  9. Roberts JL, et al. 2022. Bone. 157:116310. PubMed
  10. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  11. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  12. Grenov A, et al. 2022. Cell Rep. 39:110778. PubMed
  13. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  14. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  15. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  16. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  17. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  18. Wiedmann L, et al. 2023. Nat Commun. 14:2353. PubMed
  19. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  20. Noir S, et al. 2017. Nucleic Acids Res. 10.1093/nar/gkx203. PubMed
  21. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  22. Hirata Y, et al. 2010. Blood. 115:3930. PubMed
  23. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  24. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  25. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  26. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  27. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  28. He R, et al. 2021. J Immunol. 206:2353. PubMed
  29. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  30. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  31. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  32. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  33. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  34. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  35. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  36. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  37. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  38. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  39. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  40. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  41. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  42. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  43. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  44. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  45. Suzuki M, et al. 2021. Sci Adv. 7:. PubMed
  46. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  47. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  48. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  49. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  50. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  51. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  52. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  53. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  54. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  55. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  56. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  57. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  58. Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed
  59. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  60. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  61. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  62. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  63. Perfilyeva Y, et al. 2017. Inflammation Research. 10.1007/s00011-017-1052-4. PubMed
  64. Recher M, et al. 2012. Blood. 119:2819. PubMed
  65. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  66. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  67. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  68. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  69. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  70. Li J, et al. 2020. Elife. 9:00. PubMed
  71. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  72. Reddi RN, et al. 2021. J Am Chem Soc. 143:4979. PubMed
  73. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  74. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  75. Cervantes-Barragan L, et al. 2007. Blood . 109:1131. PubMed
  76. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  77. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  78. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  79. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  80. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  81. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  82. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  83. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  84. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  85. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  86. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  87. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  88. Reddi RN, et al. 2021. J Am Chem Soc. 143:20095. PubMed
  89. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  90. Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
  91. Saintamand A, et al. 2016. Nat Commun. 7:10730. PubMed
  92. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  93. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  94. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  95. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  96. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  97. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  98. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  99. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  100. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  101. Braikia F, et al. 2015. Mol Cell Biol. 35: 3370 - 3380. PubMed
  102. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  103. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  104. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  105. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  106. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  107. Ma K, et al. 2022. iScience. 25:104347. PubMed
  108. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  109. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  110. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  111. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  112. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  113. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  114. Zhu D, et al. 2017. Stem Cell Res Ther. 0.511805556. PubMed
  115. Sato K, et al. 2017. J Immunol. 10.4049/jimmunol.1602005. PubMed
  116. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  117. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  118. Shih F, et al. 2006. J Immunol. 176:3438. PubMed
  119. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  120. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  121. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  122. Graf R et al. 2019. Cell reports. 26(5):1098-1103 . PubMed
  123. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  124. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  125. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  126. Yammani R, et al. 2015. J Immunol. 193: 5434-5443. PubMed
  127. Escolano A, et al. 2019. Nature. 570:468. PubMed
  128. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  129. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  130. Fahey L, et al. 2011. J Exp Med. 208:987. PubMed
  131. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  132. Koide S, et al. 2022. iScience. 25:103603. PubMed
  133. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  134. Laubreton D, et al. 2020. Viruses. 12:00. PubMed
  135. Feldman S, et al. 2015. J Immunol. 194:2380. PubMed
  136. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  137. Bussey KA, et al. 2019. J Virol. 93. PubMed
  138. Li X, et al. 2018. Immunity. 48:530. PubMed
  139. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  140. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  141. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  142. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  143. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  144. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  145. Puget N, et al. 2015. Mol Cell Biol. 35:529. PubMed
  146. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  147. Odeh A Simecka J 2016. PLoS One. 11: 0155648. PubMed
  148. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  149. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  150. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  151. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  152. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  153. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  154. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  155. Cooley L, et al. 2016. Sci Rep. 6: 25840. PubMed
  156. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  157. Perper SJ, et al. 2019. J Immunol. 203:58. PubMed
  158. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  159. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  160. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  161. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  162. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
  163. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  164. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  165. Man N, et al. 2021. JCI Insight. 6:. PubMed
  166. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
  167. Schaum N, et al. 2020. Nature. 583:596. PubMed
  168. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  169. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  170. Hohmann A, et al. 2016. Nat Chem Biol. 10.1038/nchembio.2115. PubMed
  171. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  172. Zhang Y, et al. 2008. Mol Cell Biol. 28:1688. PubMed
  173. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  174. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  175. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  176. Atalis A, et al. 2022. J Control Release. 347:476. PubMed
  177. Erickson JJ, et al. 2022. Nature. 606:769. PubMed
  178. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  179. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  180. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  181. Roberts JL, et al. 2022. Bone. 157:116310. PubMed
  182. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  183. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  184. Grenov A, et al. 2022. Cell Rep. 39:110778. PubMed
  185. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  186. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  187. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  188. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  189. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  190. Wiedmann L, et al. 2023. Nat Commun. 14:2353. PubMed
  191. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  192. Noir S, et al. 2017. Nucleic Acids Res. 10.1093/nar/gkx203. PubMed
  193. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  194. Hirata Y, et al. 2010. Blood. 115:3930. PubMed
  195. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  196. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  197. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  198. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  199. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  200. He R, et al. 2021. J Immunol. 206:2353. PubMed
  201. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  202. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  203. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  204. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  205. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  206. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  207. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  208. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  209. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  210. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  211. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  212. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  213. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  214. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  215. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  216. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  217. Suzuki M, et al. 2021. Sci Adv. 7:. PubMed
  218. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  219. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  220. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  221. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  222. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  223. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  224. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  225. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  226. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  227. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  228. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  229. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  230. Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed
  231. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  232. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  233. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  234. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  235. Perfilyeva Y, et al. 2017. Inflammation Research. 10.1007/s00011-017-1052-4. PubMed
  236. Recher M, et al. 2012. Blood. 119:2819. PubMed
  237. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  238. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  239. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  240. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  241. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  242. Li J, et al. 2020. Elife. 9:00. PubMed
  243. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  244. Reddi RN, et al. 2021. J Am Chem Soc. 143:4979. PubMed
  245. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  246. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  247. Cervantes-Barragan L, et al. 2007. Blood . 109:1131. PubMed
  248. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  249. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  250. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  251. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  252. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  253. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  254. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  255. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  256. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  257. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  258. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  259. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  260. Reddi RN, et al. 2021. J Am Chem Soc. 143:20095. PubMed
  261. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  262. Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
  263. Saintamand A, et al. 2016. Nat Commun. 7:10730. PubMed
  264. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  265. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  266. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  267. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  268. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  269. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  270. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  271. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  272. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  273. Braikia F, et al. 2015. Mol Cell Biol. 35: 3370 - 3380. PubMed
  274. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  275. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  276. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  277. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  278. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  279. Ma K, et al. 2022. iScience. 25:104347. PubMed
  280. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  281. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  282. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  283. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  284. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  285. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  286. Zhu D, et al. 2017. Stem Cell Res Ther. 0.511805556. PubMed
  287. Sato K, et al. 2017. J Immunol. 10.4049/jimmunol.1602005. PubMed
  288. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  289. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  290. Shih F, et al. 2006. J Immunol. 176:3438. PubMed
  291. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  292. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  293. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  294. Graf R et al. 2019. Cell reports. 26(5):1098-1103 . PubMed
  295. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  296. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  297. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  298. Yammani R, et al. 2015. J Immunol. 193: 5434-5443. PubMed
  299. Escolano A, et al. 2019. Nature. 570:468. PubMed
  300. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  301. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  302. Fahey L, et al. 2011. J Exp Med. 208:987. PubMed
  303. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  304. Koide S, et al. 2022. iScience. 25:103603. PubMed
  305. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  306. Laubreton D, et al. 2020. Viruses. 12:00. PubMed
  307. Feldman S, et al. 2015. J Immunol. 194:2380. PubMed
  308. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  309. Bussey KA, et al. 2019. J Virol. 93. PubMed
  310. Li X, et al. 2018. Immunity. 48:530. PubMed
  311. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  312. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  313. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  314. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  315. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  316. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  317. Puget N, et al. 2015. Mol Cell Biol. 35:529. PubMed
  318. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  319. Odeh A Simecka J 2016. PLoS One. 11: 0155648. PubMed
  320. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  321. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  322. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  323. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  324. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  325. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  326. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  327. Cooley L, et al. 2016. Sci Rep. 6: 25840. PubMed
  328. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  329. Perper SJ, et al. 2019. J Immunol. 203:58. PubMed
  330. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  331. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  332. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  333. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  334. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
  335. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  336. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  337. Man N, et al. 2021. JCI Insight. 6:. PubMed
  338. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
  339. Schaum N, et al. 2020. Nature. 583:596. PubMed
  340. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  341. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  342. Hohmann A, et al. 2016. Nat Chem Biol. 10.1038/nchembio.2115. PubMed
  343. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  344. Zhang Y, et al. 2008. Mol Cell Biol. 28:1688. PubMed
RRID
AB_312996 (BioLegend Cat. No. 103211)
AB_312997 (BioLegend Cat. No. 103212)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about PTPRC on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Fire™ 780 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark YG™ 593 anti-mouse/human CD45R/B220 (Flexi-Fluor™) Antibody RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04.25.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_APC_090507
C57BL/6 mouse splenocytes stained with RA3-6B2 APC
  • RA3-6B2_APC_090507
    C57BL/6 mouse splenocytes stained with RA3-6B2 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103211 25 µg NOK231
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103212 100 µg NOK726
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45R antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  4. Atalis A, et al. 2022. J Control Release. 347:476. PubMed
  5. Erickson JJ, et al. 2022. Nature. 606:769. PubMed
  6. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  7. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  8. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  9. Roberts JL, et al. 2022. Bone. 157:116310. PubMed
  10. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  11. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  12. Grenov A, et al. 2022. Cell Rep. 39:110778. PubMed
  13. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  14. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  15. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  16. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  17. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  18. Wiedmann L, et al. 2023. Nat Commun. 14:2353. PubMed
  19. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  20. Noir S, et al. 2017. Nucleic Acids Res. 10.1093/nar/gkx203. PubMed
  21. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  22. Hirata Y, et al. 2010. Blood. 115:3930. PubMed
  23. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  24. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  25. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  26. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  27. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  28. He R, et al. 2021. J Immunol. 206:2353. PubMed
  29. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  30. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  31. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  32. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  33. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  34. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  35. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  36. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  37. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  38. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  39. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  40. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  41. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  42. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  43. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  44. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  45. Suzuki M, et al. 2021. Sci Adv. 7:. PubMed
  46. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  47. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  48. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  49. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  50. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  51. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  52. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  53. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  54. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  55. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  56. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  57. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  58. Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed
  59. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  60. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  61. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  62. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  63. Perfilyeva Y, et al. 2017. Inflammation Research. 10.1007/s00011-017-1052-4. PubMed
  64. Recher M, et al. 2012. Blood. 119:2819. PubMed
  65. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  66. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  67. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  68. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  69. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  70. Li J, et al. 2020. Elife. 9:00. PubMed
  71. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  72. Reddi RN, et al. 2021. J Am Chem Soc. 143:4979. PubMed
  73. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  74. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  75. Cervantes-Barragan L, et al. 2007. Blood . 109:1131. PubMed
  76. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  77. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  78. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  79. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  80. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  81. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  82. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  83. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  84. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  85. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  86. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  87. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  88. Reddi RN, et al. 2021. J Am Chem Soc. 143:20095. PubMed
  89. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  90. Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
  91. Saintamand A, et al. 2016. Nat Commun. 7:10730. PubMed
  92. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  93. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  94. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  95. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  96. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  97. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  98. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  99. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  100. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  101. Braikia F, et al. 2015. Mol Cell Biol. 35: 3370 - 3380. PubMed
  102. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  103. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  104. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  105. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  106. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  107. Ma K, et al. 2022. iScience. 25:104347. PubMed
  108. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  109. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  110. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  111. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  112. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  113. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  114. Zhu D, et al. 2017. Stem Cell Res Ther. 0.511805556. PubMed
  115. Sato K, et al. 2017. J Immunol. 10.4049/jimmunol.1602005. PubMed
  116. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  117. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  118. Shih F, et al. 2006. J Immunol. 176:3438. PubMed
  119. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  120. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  121. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  122. Graf R et al. 2019. Cell reports. 26(5):1098-1103 . PubMed
  123. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  124. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  125. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  126. Yammani R, et al. 2015. J Immunol. 193: 5434-5443. PubMed
  127. Escolano A, et al. 2019. Nature. 570:468. PubMed
  128. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  129. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  130. Fahey L, et al. 2011. J Exp Med. 208:987. PubMed
  131. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  132. Koide S, et al. 2022. iScience. 25:103603. PubMed
  133. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  134. Laubreton D, et al. 2020. Viruses. 12:00. PubMed
  135. Feldman S, et al. 2015. J Immunol. 194:2380. PubMed
  136. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  137. Bussey KA, et al. 2019. J Virol. 93. PubMed
  138. Li X, et al. 2018. Immunity. 48:530. PubMed
  139. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  140. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  141. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  142. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  143. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  144. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  145. Puget N, et al. 2015. Mol Cell Biol. 35:529. PubMed
  146. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  147. Odeh A Simecka J 2016. PLoS One. 11: 0155648. PubMed
  148. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  149. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  150. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  151. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  152. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  153. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  154. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  155. Cooley L, et al. 2016. Sci Rep. 6: 25840. PubMed
  156. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  157. Perper SJ, et al. 2019. J Immunol. 203:58. PubMed
  158. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  159. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  160. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  161. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  162. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
  163. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  164. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  165. Man N, et al. 2021. JCI Insight. 6:. PubMed
  166. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
  167. Schaum N, et al. 2020. Nature. 583:596. PubMed
  168. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  169. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  170. Hohmann A, et al. 2016. Nat Chem Biol. 10.1038/nchembio.2115. PubMed
  171. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  172. Zhang Y, et al. 2008. Mol Cell Biol. 28:1688. PubMed
  173. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  174. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  175. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  176. Atalis A, et al. 2022. J Control Release. 347:476. PubMed
  177. Erickson JJ, et al. 2022. Nature. 606:769. PubMed
  178. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  179. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  180. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  181. Roberts JL, et al. 2022. Bone. 157:116310. PubMed
  182. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  183. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  184. Grenov A, et al. 2022. Cell Rep. 39:110778. PubMed
  185. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  186. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  187. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  188. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  189. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  190. Wiedmann L, et al. 2023. Nat Commun. 14:2353. PubMed
  191. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  192. Noir S, et al. 2017. Nucleic Acids Res. 10.1093/nar/gkx203. PubMed
  193. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  194. Hirata Y, et al. 2010. Blood. 115:3930. PubMed
  195. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  196. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  197. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  198. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  199. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  200. He R, et al. 2021. J Immunol. 206:2353. PubMed
  201. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  202. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  203. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  204. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  205. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  206. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  207. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  208. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  209. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  210. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  211. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  212. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  213. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  214. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  215. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  216. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  217. Suzuki M, et al. 2021. Sci Adv. 7:. PubMed
  218. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  219. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  220. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  221. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  222. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  223. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  224. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  225. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  226. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  227. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  228. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  229. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  230. Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed
  231. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  232. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  233. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  234. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  235. Perfilyeva Y, et al. 2017. Inflammation Research. 10.1007/s00011-017-1052-4. PubMed
  236. Recher M, et al. 2012. Blood. 119:2819. PubMed
  237. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  238. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  239. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  240. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  241. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  242. Li J, et al. 2020. Elife. 9:00. PubMed
  243. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  244. Reddi RN, et al. 2021. J Am Chem Soc. 143:4979. PubMed
  245. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  246. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  247. Cervantes-Barragan L, et al. 2007. Blood . 109:1131. PubMed
  248. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  249. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  250. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  251. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  252. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  253. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  254. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  255. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  256. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  257. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  258. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  259. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  260. Reddi RN, et al. 2021. J Am Chem Soc. 143:20095. PubMed
  261. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  262. Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
  263. Saintamand A, et al. 2016. Nat Commun. 7:10730. PubMed
  264. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  265. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  266. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  267. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  268. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  269. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  270. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  271. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  272. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  273. Braikia F, et al. 2015. Mol Cell Biol. 35: 3370 - 3380. PubMed
  274. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  275. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  276. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  277. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  278. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  279. Ma K, et al. 2022. iScience. 25:104347. PubMed
  280. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  281. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  282. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  283. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  284. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  285. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  286. Zhu D, et al. 2017. Stem Cell Res Ther. 0.511805556. PubMed
  287. Sato K, et al. 2017. J Immunol. 10.4049/jimmunol.1602005. PubMed
  288. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  289. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  290. Shih F, et al. 2006. J Immunol. 176:3438. PubMed
  291. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  292. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  293. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  294. Graf R et al. 2019. Cell reports. 26(5):1098-1103 . PubMed
  295. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  296. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  297. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  298. Yammani R, et al. 2015. J Immunol. 193: 5434-5443. PubMed
  299. Escolano A, et al. 2019. Nature. 570:468. PubMed
  300. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  301. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  302. Fahey L, et al. 2011. J Exp Med. 208:987. PubMed
  303. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  304. Koide S, et al. 2022. iScience. 25:103603. PubMed
  305. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  306. Laubreton D, et al. 2020. Viruses. 12:00. PubMed
  307. Feldman S, et al. 2015. J Immunol. 194:2380. PubMed
  308. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  309. Bussey KA, et al. 2019. J Virol. 93. PubMed
  310. Li X, et al. 2018. Immunity. 48:530. PubMed
  311. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  312. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  313. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  314. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  315. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  316. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  317. Puget N, et al. 2015. Mol Cell Biol. 35:529. PubMed
  318. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  319. Odeh A Simecka J 2016. PLoS One. 11: 0155648. PubMed
  320. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  321. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  322. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  323. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  324. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  325. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  326. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  327. Cooley L, et al. 2016. Sci Rep. 6: 25840. PubMed
  328. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  329. Perper SJ, et al. 2019. J Immunol. 203:58. PubMed
  330. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  331. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  332. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  333. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  334. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
  335. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  336. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  337. Man N, et al. 2021. JCI Insight. 6:. PubMed
  338. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
  339. Schaum N, et al. 2020. Nature. 583:596. PubMed
  340. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  341. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  342. Hohmann A, et al. 2016. Nat Chem Biol. 10.1038/nchembio.2115. PubMed
  343. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  344. Zhang Y, et al. 2008. Mol Cell Biol. 28:1688. PubMed
RRID
AB_312996 (BioLegend Cat. No. 103211)
AB_312997 (BioLegend Cat. No. 103212)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about PTPRC on UniProt.org

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Fire™ 780 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark YG™ 593 anti-mouse/human CD45R/B220 (Flexi-Fluor™) Antibody RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04.25.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account